The store will not work correctly when cookies are disabled.
1-((1H-benzo[d]1,2,3-triazol-1-yl)methyl)-1Hbenzo[d]imidazole
ID: ALA3758357
Cas Number: 124337-36-6
PubChem CID: 639433
Max Phase: Preclinical
Molecular Formula: C14H11N5
Molecular Weight: 249.28
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: c1ccc2c(c1)ncn2Cn1nnc2ccccc21
Standard InChI: InChI=1S/C14H11N5/c1-3-7-13-11(5-1)15-9-18(13)10-19-14-8-4-2-6-12(14)16-17-19/h1-9H,10H2
Standard InChI Key: ADSRABCOOMJJBA-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 22 0 0 0 0 0 0 0 0999 V2000
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1855 -2.6254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6552 -2.9294 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7165 -1.9222 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0283 -2.6552 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7345 -4.1193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2488 -4.2866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6328 -5.6586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5406 -6.8774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0262 -6.7101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6402 -5.3200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
1 5 2 0
6 7 1 0
7 8 2 0
8 9 1 0
3 9 2 0
4 6 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 1 0
11 15 1 0
16 17 1 0
17 18 2 0
18 19 1 0
14 19 2 0
15 16 2 0
10 11 1 0
2 10 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 249.28 | Molecular Weight (Monoisotopic): 249.1014 | AlogP: 2.29 | #Rotatable Bonds: 2 |
Polar Surface Area: 48.53 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.13 | CX LogP: 2.85 | CX LogD: 2.84 |
Aromatic Rings: 4 | Heavy Atoms: 19 | QED Weighted: 0.55 | Np Likeness Score: -1.95 |
References
1. Karataş MO, Uslu H, Alıcı B, Gökçe B, Gencer N, Arslan O, Arslan NB, Özdemir N.. (2016) Functionalized imidazolium and benzimidazolium salts as paraoxonase 1 inhibitors: Synthesis, characterization and molecular docking studies., 24 (6): [PMID:26879855] [10.1016/j.bmc.2016.02.012] |